Stockholders' Equity Attributable to Parent of CITIUS ONCOLOGY, INC. from 31 Mar 2021 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
- Summary
-
CITIUS ONCOLOGY, INC. quarterly Stockholders' Equity Attributable to Parent in USD history and change rate from 31 Mar 2021 to 31 Dec 2025.
- CITIUS ONCOLOGY, INC. Stockholders' Equity Attributable to Parent for the quarter ending 31 Dec 2025 was $58,413,701, a 41% increase year-over-year.
- Source SEC data
- View on sec.gov
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)
CITIUS ONCOLOGY, INC. Quarterly Stockholders' Equity Attributable to Parent (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $58,413,701 | +$17,124,089 | +41% | 31 Dec 2025 | 10-Q | 13 Feb 2026 | 2026 | Q1 |
| Q3 2025 | $44,866,231 | -$1,274,108 | -2.8% | 30 Sep 2025 | 10-Q | 13 Feb 2026 | 2026 | Q1 |
| Q2 2025 | $32,397,913 | +$15,367,052 | +90% | 30 Jun 2025 | 10-Q | 12 Aug 2025 | 2025 | Q3 |
| Q1 2025 | $35,642,632 | +$15,795,921 | +80% | 31 Mar 2025 | 10-Q | 12 Aug 2025 | 2025 | Q3 |
| Q4 2024 | $41,289,612 | +$18,564,355 | +82% | 31 Dec 2024 | 10-Q | 13 Feb 2026 | 2026 | Q1 |
| Q3 2024 | $46,140,339 | +$20,604,679 | +81% | 30 Sep 2024 | 10-Q | 13 Feb 2026 | 2026 | Q1 |
| Q2 2024 | $17,030,861 | +$17,032,829 | 30 Jun 2024 | 10-Q | 12 Aug 2025 | 2025 | Q3 | |
| Q1 2024 | $19,846,711 | +$19,649,125 | +9945% | 31 Mar 2024 | 10-Q | 12 Aug 2025 | 2025 | Q3 |
| Q4 2023 | $22,725,257 | +$22,379,749 | +6477% | 31 Dec 2023 | 10-Q | 12 Aug 2025 | 2025 | Q3 |
| Q3 2023 | $25,535,660 | -$10,731,741 | -30% | 30 Sep 2023 | 10-K | 23 Dec 2025 | 2025 | FY |
| Q2 2023 | $1,968* | +$8,145 | 30 Jun 2023 | 10-Q | 09 Aug 2024 | 2024 | Q2 | |
| Q1 2023 | $197,586 | +$207,699 | 31 Mar 2023 | 10-Q | 09 Aug 2024 | 2024 | Q2 | |
| Q4 2022 | $345,508 | +$355,621 | 31 Dec 2022 | 10-Q | 09 Aug 2024 | 2024 | Q2 | |
| Q3 2022 | $36,267,401 | +$36,277,514 | 30 Sep 2022 | 10-K | 27 Dec 2024 | 2024 | FY | |
| Q2 2022 | $10,113* | $0 | 30 Jun 2022 | 10-Q | 20 Nov 2023 | 2023 | Q3 | |
| Q1 2022 | $10,113* | -$724 | 31 Mar 2022 | 10-Q | 20 Nov 2023 | 2023 | Q3 | |
| Q4 2021 | $10,113* | 31 Dec 2021 | 10-K | 16 Apr 2024 | 2023 | FY | ||
| Q3 2021 | $10,113* | 30 Sep 2021 | 10-Q | 28 Nov 2022 | 2022 | Q3 | ||
| Q2 2021 | $10,113* | 30 Jun 2021 | 10-Q | 28 Nov 2022 | 2022 | Q3 | ||
| Q1 2021 | $9,389* | 31 Mar 2021 | 10-Q | 28 Nov 2022 | 2022 | Q3 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.